Azilect

Azilect is a brand name for the medication rasagiline mesylate. It is a prescription drug used to treat the symptoms of Parkinson's disease. Parkinson's disease is a progressive disorder that affects the nervous system, particularly the brain. Symptoms can include tremors, stiffness, slowness of movement, and difficulty with balance and coordination.

Rasagiline is classified as a selective and irreversible inhibitor of monoamine oxidase B (MAO-B). MAO-B is an enzyme in the brain that breaks down dopamine, a neurotransmitter that plays a crucial role in controlling movement. By inhibiting MAO-B, rasagiline increases the levels of dopamine available in the brain, which helps to alleviate the motor symptoms of Parkinson's disease.

Azilect can be used as monotherapy in the early stages of Parkinson's disease or as an adjunct therapy with levodopa in more advanced stages. The dosage and frequency of administration are determined by a healthcare professional based on the individual's condition and response to treatment. Common side effects may include flu-like symptoms, headache, joint pain, and indigestion. It is important to discuss any potential side effects or interactions with a doctor. Azilect is taken orally, typically once a day.